H3N2 INFLUENZA

H3N2 INFLUENZA was reported 36 times

These drug classes are most commonly taken by patients reporting H3N2 INFLUENZA:

# Drug Count
0 Corticosteroid [EPC] 17
1 Janus Kinase Inhibitor [EPC] 5
2 Alkylating Drug [EPC] 4
3 CD20-directed Cytolytic Antibody [EPC] 3
4 CD52-directed Cytolytic Antibody [EPC] 3
5 Folate Analog Metabolic Inhibitor [EPC] 3
6 Interleukin-2 Receptor Blocking Antibody [EPC] 3
7 Anti-IgE [EPC] 2
8 Antimetabolite Immunosuppressant [EPC] 2
9 Azole Antifungal [EPC] 2
10 Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC] 2
11 Interleukin-5 Antagonist [EPC] 2
12 Loop Diuretic [EPC] 2
13 Topoisomerase Inhibitor [EPC] 2
14 Tumor Necrosis Factor Blocker [EPC] 2
15 Aldosterone Antagonist [EPC] 1
16 Antidote [EPC] 1
17 Antidote for Acetaminophen Overdose [EPC] 1
18 Antirheumatic Agent [EPC] 1
19 Aromatase Inhibitor [EPC] 1
20 Atypical Antipsychotic [EPC] 1
21 B Lymphocyte Stimulator-specific Inhibitor [EPC] 1
22 Calcineurin Inhibitor Immunosuppressant [EPC] 1
23 Calcium [EPC] 1
24 Cardiac Glycoside [EPC] 1
25 Dipeptidyl Peptidase 4 Inhibitor [EPC] 1
26 Endothelin Receptor Antagonist [EPC] 1
27 Fluoroquinolone Antibacterial [EPC] 1
28 GLP-1 Receptor Agonist [EPC] 1
29 Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC] 1
30 HMG-CoA Reductase Inhibitor [EPC] 1
31 Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] 1
32 Interleukin-17A Antagonist [EPC] 1
33 Kinase Inhibitor [EPC] 1
34 Mucolytic [EPC] 1
35 Neuraminidase Inhibitor [EPC] 1
36 Nonsteroidal Anti-inflammatory Drug [EPC] 1
37 Nucleoside Analog Antiviral [EPC] 1
38 Opioid Agonist [EPC] 1
39 Orexin Receptor Antagonist [EPC] 1
40 Platinum-based Drug [EPC] 1
41 Purine Antimetabolite [EPC] 1
42 RANK Ligand Inhibitor [EPC] 1
43 Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] 1
44 Soluble Guanylate Cyclase Stimulator [EPC] 1
45 Sulfone [EPC] 1
46 Vitamin B12 [EPC] 1
47 Vitamin C [EPC] 1
48 Vitamin D [EPC] 1